Global Gene Corp publicizes R&D funding in genomics – Times of India

NEW DELHI: Global Gene Corp on Tuesday introduced R&D funding within the largest genome sequencing programme for populations of the Indian subcontinent, with a view to gaining a greater understanding of illnesses and allelic structure.
The analysis will resolve the genomic information bias that may be a crucial barrier to attaining the complete potential of genomics. Currently, 78 per cent of the world’s genomic information is derived from European ancestry, whereas the populations of the Indian subcontinent contribute lower than 2 per cent.
Over the following 5 years, the funding will create 110 extremely expert jobs, principally primarily based within the R&D centre in Wellcome Genome Campus, Cambridge. The campus is the location of the Human Genome Project and likewise hosts Sanger Institute and EBI-EMBL.
Global Gene Corp is being supported by Invest India and the UK Department of International Trade on this analysis funding.
UK Prime Minister Boris Johnson stated commenting on the funding stated that he’s happy to know Global Gene Corp is among the many newest Indian corporations investing in UK’s healthcare sector and “driving economic growth”.
“Trade and investment between the UK and India are creating good jobs and sustaining livelihoods in both of our countries,” stated Johnson.
On the UK and Indian management supporting the collaboration, Sumit Jamuar, chairman and CEO of Global Gene Corp stated that genomics has develop into extra related within the Covid-19 backdrop given the way it can assist uncover the following technology of medicine.
“The UK is at the forefront of the genomics revolution with her Genome UK strategy. We are delighted to be investing in cutting-edge capabilities at the intersection of genomics and machine learning to achieve our vision,” Jamuar.
Deepak Bagla, CEO Invest India stated this UK-India partnership is in step with PM Narendra Modi’s “vision of Ayushmaan Bharat and National Healthcare Mission”.
“We truly believe that the genomic revolution will have an impact on the lives of billions. Global Gene Corp will make this revolution a reality,” stated Bagla.
Winner of the $1 million Roddenberry Prize for Science 2020, Global Gene Corp is a drug discovery platform working on the convergence of genomics and machine studying. It is pushed by a various and deeply phenotyped genomic data-lake ever compiled which contains nearly 500,000 sequences
It additionally attracts insights from one of many largest and deepest behavioural well being longitudinal Real-World Data libraries consisting of over 50 million rows collected over 20 years.

FacebookTwitterLinkedinEMail

LEAVE A REPLY

Please enter your comment!
Please enter your name here